ClinicalTrialsFinder

Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Chiba, Tiba [Chiba]

1 recruitingChiba, Tiba [Chiba], Japan

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma

Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.450 enrolled22 locationsNCT06238843